Rapid Control of Government Economic Environment Management Cost Based on Balanced Score Card

por Wang, Yumei, Shen, Zhirong, Zhou, Yicheng
Publicado 2022

Pterisolic Acid B is a Nrf2 Activator by Targeting C171 within Keap1-BTB Domain

por Dong, Ting, Liu, Weilong, Shen, Zhirong, Li, Lin, Chen, She, Lei, Xiaoguang
Publicado 2016

Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells

por Qi, Chen, Wang, Xin, Shen, Zhirong, Chen, She, Yu, Hong, Williams, Noelle, Wang, Gelin
Publicado 2018

Arrayed mutant haploid embryonic stem cell libraries facilitate phenotype-driven genetic screens

por Liu, Guang, Wang, Xue, Liu, Yufang, Zhang, Meili, Cai, Tao, Shen, Zhirong, Jia, Yuyan, Huang, Yue
Publicado 2017

EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment

por Zhang, Hongjuan, Zhan, Cheng, Ke, Ji, Xue, Zhiqiang, Zhang, Aiqun, Xu, Kaifeng, Shen, Zhirong, Yu, Lei, Chen, Liang
Publicado 2015

MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation

por Wang, Yuan, Yan, Ping, Liu, Zhentao, Yang, Xiaodan, Wang, Yaping, Shen, Zhirong, Bai, Hua, Wang, Jie, Wang, Zhijie
Publicado 2015

Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment

por Zhang, Hongjuan, Zhan, Cheng, Ke, Ji, Xue, Zhiqiang, Zhang, Aiqun, Xu, Kaifeng, Shen, Zhirong, Yu, Lei, Chen, Liang
Publicado 2018

Evaluation of the EdgeSeq Precision Immuno-Oncology Panel for Gene Expression Profiling From Clinical Formalin-Fixed Paraffin-Embedded Tumor Specimens

por Shi, Yang, Ma, Xiaopeng, Shen, Wei, Liu, Tengfei, Liang, Liang, Liu, Silu, Shen, Zhirong, Zhang, Yun, Zhang, Pei
Publicado 2022

P1239: BRUTON TYROSINE KINASE (BTK) PROTEIN DEGRADER BGB-16673 IS LESS APT TO CAUSE, AND ABLE TO OVERCOME VARIABLE BTK RESISTANCE MUTATIONS COMPARED TO OTHER BTK INHIBITORS (BTKI)

por Feng, Xiaoyu, Wang, Yangyang, Long, Tao, Bai, Lanyue, Yang, Xiaojiao, Yang, Ailing, Chen, Xiangmei, Puig, Oscar, Yue, Yangbo, Shen, Zhirong
Publicado 2023

The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma

por Lu, Zhihao, Yang, Silu, Luo, Xuerui, Shi, Yang, Lee, Jong-Seok, Deva, Sanjeev, Liu, Tianshu, Chao, Yee, Zhang, Yun, Huang, Ruiqi, Xu, Yaling, Shen, Zhirong, Shen, Lin
Publicado 2022

Aldehyde dehydrogenase 1A1 increases NADH levels and promotes tumor growth via glutathione/dihydrolipoic acid-dependent NAD(+) reduction

por Wang, Baiyun, Chen, Xue, Wang, Zixi, Xiong, Wei, Xu, Tao, Zhao, Xinyuan, Cao, Yang, Guo, Yanru, Li, Lin, Chen, She, Huang, Song, Wang, Xiaodong, Fang, Min, Shen, Zhirong
Publicado 2017

P1219: BGB-16673, A BTK DEGRADER, OVERCOMES ON-TARGET RESISTANCE FROM BTK INHIBITORS AND PRESENTS SUSTAINABLE LONG-TERM TUMOR REGRESSION IN LYMPHOMA XENOGRAFT MODELS

por Wang, Haitao, Hou, Xinfeng, Zhang, Wenjing, Wang, Yiwen, LI, Lin, LI, Yang, Luweihing, Bruce, XI, Min, Song, Jiayun, Zhu, Xinxin, Zhou, Liyun, Chen, Xiangmei, Yu, Yiling, Jin, Wei, Shen, Zhirong
Publicado 2023

ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations

por Wang, Zhijie, Li, Zhenxiang, Ding, Xiaosheng, Shen, Zhirong, Liu, Zhentao, An, Tongtong, Duan, Jianchun, Zhong, Jia, Wu, Meina, Zhao, Jun, Zhuo, Minglei, Wang, Yuyan, Wang, Shuhang, Sun, Yu, Bai, Hua, Wang, Jie
Publicado 2015

Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors

por Ye, Dingwei, Desai, Jayesh, Shi, Jingwen, Liu, Si-Yang Maggie, Shen, Wei, Liu, Tengfei, Shi, Yang, Wang, Dan, Liang, Liang, Yang, Silu, Ma, Xiaopeng, Jin, Wei, Zhang, Pei, Huang, Ruiqi, Shen, Zhirong, Zhang, Yun, Wu, Yi-Long
Publicado 2023

Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis

por Song, Yuqin, Gao, Quanli, Zhang, Huilai, Fan, Lei, Zhou, Jianfeng, Zou, Dehui, Li, Wei, Yang, Haiyan, Liu, Ting, Wang, Quanshun, Lv, Fangfang, Guo, Haiyi, Zhao, Xia, Wang, Dan, Zhang, Pei, Wang, Yidi, Wang, Lei, Liu, Tengfei, Zhang, Yun, Shen, Zhirong, Huang, Jane, Zhu, Jun
Publicado 2022

Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor

por Xiong, Yao, Guo, Yin, Liu, Ye, Wang, Hexiang, Gong, Wenfeng, Liu, Yong, Wang, Xing, Gao, Yajuan, Yu, Fenglong, Su, Dan, Wang, Fan, Zhu, Yutong, Zhao, Yuan, Wu, Yiyuan, Qin, Zhen, Sun, Xuebing, Ren, Bo, Jiang, Bin, Jin, Wei, Shen, Zhirong, Tang, Zhiyu, Song, Xiaomin, Wang, Lai, Liu, Xuesong, Zhou, Changyou, Jiang, Beibei
Publicado 2020

An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models

por Chen, Xin, Xue, Liu, Ding, Xiao, Zhang, Jing, Jiang, Lei, Liu, Sha, Hou, Hongjia, Jiang, Bin, Cheng, Liang, Zhu, Qing, Zhang, Lijie, Zhou, Xiaosui, Ma, Jie, Liu, Qi, Li, Yucheng, Ren, Zhiying, Jiang, Beibei, Song, Xiaomin, Song, Jing, Jin, Wei, Wei, Min, Shen, Zhirong, Liu, Xuesong, Wang, Lai, Li, Kang, Zhang, Tong
Publicado 2022

Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder

por Zong, Liang, Guan, Jing, Ealy, Megan, Zhang, Qiujing, Wang, Dayong, Wang, Hongyang, Zhao, Yali, Shen, Zhirong, Campbell, Colleen A, Wang, Fengchao, Yang, Ju, Sun, Wei, Lan, Lan, Ding, Dalian, Xie, Linyi, Qi, Yue, Lou, Xin, Huang, Xusheng, Shi, Qiang, Chang, Suhua, Xiong, Wenping, Yin, Zifang, Yu, Ning, Zhao, Hui, Wang, Jun, Wang, Jing, Salvi, Richard J, Petit, Christine, Smith, Richard J H, Wang, Qiuju
Publicado 2015